SCHEMBL25041243

SCHEMBL25041243

CCCN/C=C\NCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20080360 0.90 ADH1B (0.56)
SCHEMBL4201267 0.90 ADH1B (0.56)
SCHEMBL4201273 0.90 ADH1B (0.56)
SCHEMBL446127 0.83
SCHEMBL446126 0.83
SCHEMBL19886275 0.83
SCHEMBL19820346 0.79
SCHEMBL20079189 0.79 ADH1B (0.55)
SCHEMBL13622092 0.79
SCHEMBL7903017 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4201941-A1 PYRAZOLE BORONIC ACID COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USES THEREOF Beijing Songrun Pharmaceutical Technology Co., Ltd. (CN) 2023-06-28 EP disclosed
US-20230051595-A1 CORNEAL IMPLANTS FOR TREATING ECTATIC CORNEAL DISEASE RVO 2.0, INC. D/B/A OPTICS MEDICAL (US) 2023-02-16 US disclosed